It has also been shown that patients with PMs have increased frequencies of CD4+ memory T cells which express the checkpoint receptors PD-1, VISTA, and TIGIT in the omental fat when compared to patients with only a primary CRC tumor (10). This evidence concerns the gene CD4 and neoplasm.